Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 269.50
Bid: 268.50
Ask: 269.50
Change: -0.50 (-0.19%)
Spread: 1.00 (0.372%)
Open: 268.50
High: 270.00
Low: 268.50
Prev. Close: 270.00
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report April 2021

10 May 2021 07:00

RNS Number : 9718X
Ruffer Investment Company Limited
10 May 2021
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for April 2021.

 http://www.rns-pdf.londonstockexchange.com/rns/9718X_1-2021-5-7.pdf

 

 

 

During April, the Company's net asset value appreciated by 0.9% and the share price rose by 0.5%. This compared with a rise of 4.3% in the FTSE All-Share total return index.

 

After one of the worst quarters for US bonds this century, and the steepest fall in the Barclays Long Treasury Index in 40 years, it was inevitable there would be some form of pause. Having peaked on 31 March at 1.74%, the US 10-year bond yield finished the month at 1.63%. This move lower boosted the performance of the Company's positions in gold and inflation-linked bonds. Earlier this year, gold had been doubly punished by the combination of rising yields and a rallying US dollar, but two recent tactical changes in the portfolio's asset allocation have helped performance. First, we added to bullion and selected gold mining equities during March and April, having reduced gold exposure last summer in anticipation of a reflationary shift in markets ahead of the vaccine announcements in November. Gold-related investments contributed 50bps to performance during the month. Secondly, we took profits in some of the interest rate options that protected the portfolio so effectively as bond yields rose during the first quarter of 2021, thereby allowing us to capture some of the rebound in inflation-linked bonds. This combination of index-linked bonds, gold, and interest rate protections, having been essentially neutral during the first quarter, contributed positively as US bond yields receded.

 

So, where next? Was April a pause for breath before a further move higher in yields and consequent move lower in bond prices? We think so but there will be an important shift in emphasis -we have probably seen the end of US reflation in isolation. The next leg down for conventional bonds will probably be driven by positive growth surprises from Europe, as the continent sees a sustained pickup in vaccination rates and starts to exit from lockdown. At the same time there appears to be growing political support for meaningful fiscal policy deployment in the coming months. This is a playbook we have already seen, except the baton is being passed from the US to continental Europe. It was instructive that the German 10-year bund yield rose 9bps over the month, in stark contrast to the moves seen in the US.

 

 

The Company's index-linked bonds, which we reduced slightly through sales of US TIPS during April, are shielded by interest rate options so they retain their inflation protection but are buttressed against the powerful economic rebound we expect to see through 2021. Our equities remain concentrated in economically sensitive and cyclical companies. This equity bias, combined with protection against rising nominal bond yields, means the Company is positioned for reflation, but still protected from inflation. In a world where fiscal policy dominates, inflation is the risk all investors should be guarding against. But conventional portfolios, hamstrung by the fallacy of benchmarks, are pointing in the wrong direction. They back-test well in the disinflationary world of the last 40 years, but are institutionally wired to the assets that performed well in the last market regime rather than to those opportunities which exist in the new one

 

 

 

 

 

 

 

 

 

 

Enquiries:

 

Praxis Fund Services Limited

Gail Adams

DDI: +44(0)1481 755584

Email: ric@praxisifm.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCBXGDUCUGDGBR
Date   Source Headline
1st May 20241:35 pmRNSNet Asset Value(s)
1st May 202411:36 amRNSTotal Voting Rights
24th Apr 20242:21 pmRNSNet Asset Value(s)
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20242:19 pmRNSNet Asset Value(s)
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20242:09 pmRNSNet Asset Value(s)
10th Apr 202410:31 amRNSMonthly Investment Report - March 2024
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20244:33 pmRNSDirector/PDMR Shareholding
9th Apr 20247:07 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20242:25 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:39 pmRNSNet Asset Value(s)
2nd Apr 202410:27 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:14 amRNSTransaction in Own Shares
27th Mar 20241:37 pmRNSNet Asset Value(s)
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20242:58 pmRNSNet Asset Value(s)
18th Mar 20247:30 amRNSRuffer LLP Senior Management Share Purchase
18th Mar 20247:15 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSNet Asset Value(s) (replacement)
15th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 202412:52 pmRNSNet Asset Value(s)
13th Mar 20247:30 amRNSBlock listing Interim Review
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSMonthly Investment Report - February 2024
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSKepler Trust Intelligence: New Research
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202411:47 amRNSNet Asset Value(s)
1st Mar 202412:04 pmRNSNet Asset Value(s)
1st Mar 202410:34 amRNSTotal Voting Rights
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:01 amRNSDividend Declaration
29th Feb 20247:00 amRNSHalf-year Report
28th Feb 202412:11 pmRNSNet Asset Value(s)
28th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20248:09 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.